According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032.
Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...
According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032.
Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...
According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030.
Meningococcal polysaccharide vaccines are immunogenic preparations...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt